Sentiment Report: Blackrock Health Sciences Trust (NYSE:BME)

September 16, 2018 - By Vernon Prom

Sentiment for Blackrock Health Sciences Trust (NYSE:BME)

Blackrock Health Sciences Trust (NYSE:BME) institutional sentiment decreased to 1.33 in 2018 Q2. Its down -0.34, from 1.67 in 2018Q1. The ratio has dropped, as 12 funds started new and increased equity positions, while 9 sold and reduced stakes in Blackrock Health Sciences Trust. The funds in our partner’s database now own: 677,303 shares, down from 766,135 shares in 2018Q1. Also, the number of funds holding Blackrock Health Sciences Trust in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 5 Increased: 9 New Position: 3.

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The company has market cap of $376.70 million. The fund is managed by BlackRock Advisors, LLC. It has a 11.27 P/E ratio. It invests in the public equity markets of the United States.

The stock decreased 1.00% or $0.41 during the last trading session, reaching $40.5. About 23,356 shares traded. BlackRock Health Sciences Trust (NYSE:BME) has risen 11.04% since September 16, 2017 and is uptrending. It has underperformed by 4.58% the S&P500.

Arete Wealth Advisors Llc holds 0.11% of its portfolio in BlackRock Health Sciences Trust for 11,549 shares. First Allied Advisory Services Inc. owns 32,193 shares or 0.05% of their US portfolio. Moreover, Cordasco Financial Network has 0.03% invested in the company for 750 shares. The California-based Clenar Muke Llc has invested 0.02% in the stock. Bb&T Securities Llc, a Virginia-based fund reported 16,384 shares.

BlackRock Health Sciences Trust (NYSE:BME) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.